Adicet Bio, Inc. — Director's Dealing 2021

Apr 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-04-20

Reporting Person: Schor Chen (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-20	Common Stock	S	8982	$12.0051	Disposed	125764	Indirect
2021-04-20	Common Stock	S	7484	$12.0051	Disposed	104777	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.76 to $12.27, inclusive.

F3: Represents 125,764 shares held directly by an irrevocable family trust having an independent trustee.

F4: Represents 104,777 shares held directly by an irrevocable family trust having an independent trustee.